Protein-Inhibiting Therapy May Reduce Stem-cell Transplant Complication GVHD – Lymphoma News Today
Lymphoma News Today |
Protein-Inhibiting Therapy May Reduce Stem–cell Transplant Complication GVHD
Lymphoma News Today Researchers are a step closer to preventing graf-versus-host-disease (GVHD), a common life-threatening complication in patients receiving stem–cell transplants. In a new study, a novel therapy that inhibits two proteins involved in T-cell activation … |
